CBD - Frequently Asked Questions
CBD, an acronym for cannabidiol, is an essential component of medical marijuana. It is one of the two major active compounds present in the Cannabis sativa plant, the otherbeing delta-9-tetrahydrocannabinol (THC). Both of these produce feelings of relaxation and calm, but the main difference is CBD is not psychoactive. It means CBD intake is not associated with a high, or potential for abuse or dependence.
CBD imparts its effect on the body by influencing the CB1and CB2 receptors of the endocannabinoid system (ECS).  The endocannabinoid system (ECS) normally helps in the regulation of certain functions such as appetite, sleep, mood, immune response, memory, fertility, and the perception of pleasure and pain; regardless of the CBD use. CB1 receptors are present in the central nervous system (CNS) and govern coordination, movement, appetite, pain, mood, and memory. CB2 receptors are primarily found in the peripheral nervous system (PNS) and regulate immune cell functions, including pain and inflammation. CBD can also modulate serotonin receptors, which explains its positive effects on anxiety,depression, and insomnia.
CBD use is associated with numerous health benefits.
A) It is used for the management of chronic pain.  It can affect pain perception by influencing both the central and peripheral nervous systems.
B) It is used for treating many psychological conditions.  It helps in improving depression and reducing anxiety. It is also useful for the treatment of post-traumatic stress disorder(PTSD) and substance abuse disorders.
C) It has a sedative effect and promotes peaceful sleep. 
D) It has an anti-inflammatory effect.  It suppresses unnecessary inflammation and thus aids in alleviating the symptoms of chronic inflammatory disorders.
E) It improves seizures and epilepsy. 
F) It strengthens the
cardiovascular system. 
G) It is used as a topical therapy for treating glaucoma. 
H) It arrests the growth and progression of some cancers. 
In most cases, CBD is well-tolerated; however,there is a slight chance of experiencing some unwanted effects. The risk of having a side effect is increased when it is contaminated with other compounds. The most common side effects that occur after taking CBD are dry mouth, diarrhea,reduced appetite, fatigue, and low blood pressure. Though it is not euphoric,it can sometimes lead to light-headedness and drowsiness. 
CBD is also used topically, but there is not enough data on its possible toxic effects on the skin and is generally regarded safe.
A rare side effect of CBD that can occur in people with chronic liver disease is acute liver injury.  Another rare side effect is, high doses of CBD can worsen the motor symptoms in Parkinson’s disease. 
CBD can interact with certain drugs; it is recommended to consult your healthcare provider before you start using it.
CBD interacts with other sedatives which results in additive effects and excessive inhibition of the receptors in the central nervous system. The sleep induced by CBD is calming and wake-inducing, but it is better to avoid the combined use of CBD and sleeping pills.
CBD slows down the metabolism of blood-thinning drugs such as warfarin.  This allows these drugs to remain in the body for a longer period, increasing the risk of bleeding.
CBD is an effective therapy for epilepsy. In certain circumstances, CBD may produce undesired effects by interacting with other antiepileptic drugs. It was found in a study that at low doses, CBD does not produce antiepileptic effects, instead, it inhibits the cytochrome p450, which is responsible for the metabolism of clobazam and narclobazam. Prolonged availability of these drugs can result in more aggressive seizures.  More Recent studies, however, regard CBD as a safe and effective therapy in epilepsy patients receiving clobazam.
CBD interacts with anti-cancer drugs by inhibiting their metabolism. The principle of chemotherapy is, drugs work only in the therapeutic range, as both decreased and increased concentrations produce undesired effects.  The increased availability of chemotherapeutic agents, therefore, has negative consequences.
CBD provides a wide range of therapeutic advantages by interacting and affecting the endogenous regulatory systems of the body. However, its ability to inhibit cytochrome p450,  which metabolizes many drugs, produces complex drug interactions and adverse effects.Therefore, people who are using the following medications should not use CBD.
· Calcium channel blockers
· Anti-histamine (anti-allergic)
· Prokinetics (motility drugs)
· Anti-HIV drugs
· Proton pump inhibitors (reflux drugs)
It should also be avoided in the following conditions:
· CBD has an adverse effect of lowering blood pressure;therefore, people who usually are hypotensive must avoid using it.
· CBD can worsen Parkinson’s disease, so it is not recommended for Parkinson’s patients.
· CBD deranged liver enzymes. People with pre-existing liver disease are at the greatest risk for further deterioration of hepatic function; thus, they should avoid it.
Many CBD products are not purified completely and produce feelings of euphoria because of contamination with THC. Other than euphoria, these contaminants can accumulate over time in the body and results in long-term consequences. Clinically, it is difficult to distinguish the effects of CBD and THC, as both are sedative and promote sleep, making the selection of the right product difficult for the consumer.
A simple clue is that CBD promotes peaceful and calming sleep; while, THC produces restless sleep. Additionally, manufacturers also mention the percentage of impurities on the product, which can also help in selecting pure CBD. Hemp Studios CBD products are 100% THC free, and hence only produce desired effects.
CBD is a considerably safe product, and so far, no case of fatal overdose is ever reported. Its long-term use is not associated with any kind of adverse outcomes. It is well-tolerated and even in very high concentrations, the evidence of negative consequences is lacking.  It can, however, potentially cause problems in those having pre-existing medical conditions.
Tolerance is a phenomenon in which the body becomes used to a certain concentration of drug and stops responding to it further. In that case, there is a need to increase the dose of the drug. CBD does not produce tolerance even with long-term use in large quantities.
There is not much data on the effects of CBD on the growing baby. Therefore, pregnant women must avoid using it, as the mother shares everything that goes into her body with her baby. Similarly, lactating women should also not consume CBD, as the risk to the baby is not established. Here are somethings that women must know.
· If it is really necessary to use CBD for therapeutic purpose, then the mother should, atleast, avoid in the first trimester, which is the period of organogenesis (formation of organs). Any negative stimulus in this period may lead to birth defects.
· If a woman is planning to conceive, she must avoid or cautiously use CBD.
· Lactating Women should not consume CBD two to three hours before feeding the baby.
Before using CBD for medical purposes, one must know that the benefits of CBD are not confirmed by FSA, EFSA & FDA-approved research. It is not for the diagnosis, treatment, cure, or prevention of any disease, and also not an alternative to conventional allopathic medicine. Pregnant and lactating women should not use CBD. It is best not to give to children unless medical advice has been taken. Before using CBD, it is better to take advice from a healthcare professional, particularly for those who are already taking some other medicine.
The information provided on this page is no substitute for doctors’ advice. This page does not promote self-medication or intend to stop medical treatment. It is advised to always consult a physician before starting any therapy.
Get in Touch
You are encouraged to contact us through our contact page. Please let us know about your concerns. We will happily assist you.
1. Zou, S., & Kumar, U. (2018). Cannabinoid Receptors and the Endocannabinoid System:Signaling and Function in the Central Nervous System. International Journal of molecular sciences, 19(3), 833.
2. Russo E. B.(2008). Cannabinoids in the management of difficult to treat pain. Therapeutics And clinical risk management, 4(1), 245–259.
3. Sarris, J.,Sinclair, J., Karamacoska, D., Davidson, M., & Firth, J. (2020). Medicinal Cannabis for psychiatric disorders: a clinically-focused systematic review. BMC psychiatry, 20(1), 24.
4. Kesner, A. J.,& Lovinger, D. M. (2020). Cannabinoids, Endocannabinoids, and Sleep. Frontiersin molecular neuroscience, 13, 125.
5. Atalay, S.,Jarocka-Karpowicz, I., & Skrzydlewska, E. (2019). Antioxidative and Anti-Inflammatory Properties of Cannabidiol. Antioxidants (Basel, Switzerland), 9(1),21.
6. Silvestro, S.,Mammana, S., Cavalli, E., Bramanti, P., & Mazzon, E. (2019). Use of Cannabidiol in the Treatment of Epilepsy: Efficacy and Security in Clinical Trials. Molecules (Basel, Switzerland), 24(8), 1459.
7. Jadoon, K. A.,Tan, G. D., & O'Sullivan, S. E. (2017). A single dose of cannabidiol reduces blood pressure in healthy volunteers in a randomized crossover study. JCI insight, 2(12), e93760.
8. Tomida, I.,Pertwee, R. G., & Azuara-Blanco, A. (2004). Cannabinoids and glaucoma. The British journal of ophthalmology, 88(5),708–713.
9. Dariš, B.,Tancer Verboten, M., Knez, Ž., & Ferk, P. (2019). Cannabinoids in cancer treatment: Therapeutic potential and legislation. Bosnian journal of basic medical sciences, 19(1), 14–23.
10. Huestis, M. A., Solimini, R., Pichini, S., Pacifici, R.,Carlier, J., & Busardò, F. P. (2019). Cannabidiol Adverse Effects and Toxicity. Current neuropharmacology, 17(10), 974–989.
11. Ewing, L. E., Skinner, C. M., Quick, C. M., Kennon-McGill,S., McGill, M. R., Walker, L. A., ElSohly, M. A., Gurley, B. J., Koturbash, I. (2019). Hepatotoxicity of a Cannabidiol-Rich Cannabis Extract inthe Mouse Model. Molecules (Basel, Switzerland), 24(9),1694.
12. Stampanoni Bassi, M.,Sancesario, A., Morace, R., Centonze, D., & Iezzi, E. (2017). Cannabinoids And Parkinson's Disease. Cannabis and cannabinoid research, 2(1),21–29.
13. Grayson, L., Vines, B., Nichol, K., Szaflarski, J. P., & UAB CBD Program (2017). An interaction between warfarin and cannabidiol, a case report. Epilepsy & behavior case reports, 9, 10–11.
14. Bornheim, L. M., Everhart, E. T., Li, J., & Correia, M.A. (1993). Characterization of cannabidiol-mediated cytochrome P450inactivation. Biochemical pharmacology, 45(6),1323–1331.
15. Newell D. R. (2002). Getting the right dose in cancer chemotherapy--time to stop using surface area?. British journal of cancer, 86(8), 1207–1208.
16. Jiang, R., Yamaori, S., Okamoto, Y., Yamamoto, I., & Watanabe, K. (2013). Cannabidiol is a potent inhibitor of the catalytic activity of cytochrome P450 2C19. Drug metabolism and pharmacokinetics, 28(4),332–338.
17. Iffland, K., & Grotenhermen, F. (2017). An Update on Safety and Side Effects of Cannabidiol: A Review of Clinical Data and Relevant Animal Studies. Cannabis and cannabinoid research, 2(1),139–154.